Skip to main content

Bacteriophage: Mr. Nice Guys of the Virus World

 It's widely accepted that HIV, Hepatitis C, Ebola, and the ongoing coronavirus have acquired a bad reputation for viruses due to their aggressive and infectious nature. But actually, there are nice guys in the virology world, microscopic bacteriophages. Different from dreadful bad viruses that will invade the host cell to take over the cellular machinery, release more infectious viral particles, and finally cause illness, phages are protective viruses that can attack and destroy bacteria.

 

About Phages

 

Bacteriophage, or known as phage, whose name is derived from the Greek word phagein, indicating the eater of bacteria. These spidery-looking viruses have a population of over 1031, larger than the total number of all other organisms, including bacteria, remaining the most abundant life-form on the planet. They could be found almost everywhere bacteria exist, including water, air, soil, the mucous membrane lining of digestive, respiratory, and reproductive tracts in bodies.

 

Phages are generally classified into virulent and temperate phages according to whether they cause host cell lysis. Virulent phages kill bacteria by infecting bacteria and lysing host cells, while the temperate bacteriophages integrate genes into bacterial DNA, which will synchronously replicate with hosts' DNA without causing cell lysis.

 

Bacteriophages As Therapy

 

With the powerful nature of killing bacteria and the undeniable fact that antibiotic-resistant infections are increasingly causing deaths, phages are chosen as the potential anti-bacterial therapies.

 

Compared to antibiotic treatments, bacteriophage therapy represents more excellence in different aspects. One obvious upside to phage therapy is that no obvious side effect is observed in the patients. Different from antibiotics that work on all bacteria, including the good ones, phages only attack a specific type or group of bacteria. Besides, phage-based therapies do not depend on dosage so much.

 

Although bacteria will also develop resistance to phages to survive, it takes less time to develop new phage therapies than novel antibiotic development. Moreover, the biological nature of phages enables them to evolve along with bacteria if they adjust to escape from the phages.

 

Phages have been allowed to treat dysentery, sepsis caused by Staphylococcus aureus, salmonella infections, and skin infections in some European and Asia countries and are approved by the FDA and USDA in the USA for treating processed poultry and meat products.

 

The Future of Phages

 

Public usage of phages as therapeutics still is an open case due to lack of research. However, it's undeniable that both unmodified and engineered phages keep attracting researchers in various fields. For instance, researchers use phage display to modify and isolate antibodies for in vitro and in vivo diagnostic and therapeutic purposes. Furthermore, phage or phage display vaccines could contribute to treating bacterial and viral pathogens, as well as cancer diseases. To sum up, bacteriophages are the Mr. nice guys in the virus world in the forms of reporter phages, labeled phages, therapeutic phages, etc.

Labels:

Comments

Post a Comment

Popular posts from this blog

Review: Creative Biolabs' Model-org Antibodies Fluorescently Labeling Services

Model organisms (Model-org) are non-human species, from which researchers can get insights into other organisms in biological research processes. Various model organism species such as zebrafish, flies, yeast, and rice, greatly contribute to the basic and clinical research in animal husbandry, fishery ， agriculture, forestry, etc.   Investigations on model organisms can be aided by antibody labeling when samples of interest need to be detected, isolated, or purified, though the selection of a proper label can be a challenge.   To select the best antibody labeling way for our Model-org project, we then found Creative Biolabs, one of the most well-established CROs for antibody development. After a comprehensive discussion and consultancy with the scientists at Creative Biolabs, fluorescent tags were  suggested based on our research direction. Fluorescent labels are directly conjugated to the antibody of interest, indicating that we can directly detect the number of fluoresc...
Post a Comment
Read more

Metagenomics Enhances Infectious Disease Surveillance

  Infectious lower respiratory diseases and diarrheal diseases are the leading causes of death globally . And the ongoing COVID-19 pandemic, which has contributed to 4.1 million deaths in 2019, once again is reminding the necessity of proactively identifying early signs of infectious disease outbreaks before things are getting worse. Conventional microbial diagnostics techniques would identify pathogens under specific culture conditions by serological detection of pathogen-associated antibodies or microbial genetic investigation using PCR, but these methods have been seen obvious shortcomings in pathogen coverage. It's highly required to find advanced scientific tools that are more sensitive even with a low microbial load or when targeted microorganisms are not suitable for  in vitro  culture, for which metagenomic approaches that can profile all DNA or RNA of a patient sample are increasingly catching the eyes of researchers.   How metagenomics can be used in infect...
Post a Comment
Read more

Unmodified Bacteriophages Research Updates

  R ecent research conducted by researchers from Yale University is published in  Applied and Environmental Microbiology , suggesting  that natural bacteriophage, or phage, can kill dysentery-causing bacteria and reduce virulence in surviving bacteria. It's a piece   of  inspiring news as  treating dysentery has become a challenge with the rising antibiotic resistance.   Background   Shigella flexneri , the culprit causing contagious infection marked by inflammatory diarrhea and dysentery in sub-Saharan Africa and southern Asia, kills about 160,000 people globally every year. The World Health Organization (WHO) takes priority to this pathogen in terms of increasing cases, antimicrobial resistance, and limited treatment options.   S. flexneri  is active primarily in low-income countries, like southern Asia and sub-Saharan Africa. In these places, dirty drinking water is a concern causing dysentery, while antibiotics are expensive and unav...
Post a Comment
Read more